仰卧位与俯卧位下使用磁共振直线加速器进行单次部分乳腺照射
本研究对20例曾接受单次术前加速部分乳腺照射的cTis或低危cT1N0M0非小叶性乳腺癌患者,在1.5T磁场下生成7野共面调强放疗计划。所有磁共振直线加速器计划均满足覆盖和预定义危及器官约束;俯卧位在胸壁和同侧肺剂量上似乎更有利,同侧乳腺未见剂量学差异。
要点
- 所有磁共振直线加速器计划均满足覆盖和预定义危及器官约束。
- 俯卧位在胸壁和同侧肺剂量上似乎较仰卧位更有利。
- 同侧乳腺未见剂量学差异;皮肤或心脏无某一治疗体位明显更优。
核心结论
- 基于磁共振直线加速器的单次加速部分乳腺照射至完整肿瘤在低危乳腺癌患者中是一种有前景且剂量学可行的策略。
- 初步危及器官剂量学倾向于俯卧位放疗体位。
研究设计与样本
- 对20例cTis或低危cT1N0M0非小叶性乳腺癌患者生成额外调强放疗计划,这些患者此前已接受仰卧位(n=10)或俯卧位(n=10)单次术前加速部分乳腺照射。
- 计划采用7个共面束流,在1.5T磁场存在下生成;处方剂量为大体肿瘤20 Gy、临床靶体积15 Gy。
- 评估达到当前临床实践所用预定义危及器官约束的计划百分比,并比较俯卧位与仰卧位、磁共振直线加速器计划与临床已实施计划之间的剂量学差异。
主要发现
- 所有磁共振直线加速器计划均满足覆盖和预定义危及器官约束。
- 俯卧位相比仰卧位在胸壁和同侧肺剂量上似乎更有利。
- 同侧乳腺未见剂量学差异。
- 由于各参数间剂量学存在差异,皮肤或心脏方面无某一治疗体位明显更有利。
- 磁共振直线加速器计划与临床计划总体可比,仅有轻微绝对剂量学差异。
关键数值与推荐
- 处方剂量:大体肿瘤20 Gy,临床靶体积15 Gy。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In selected patients with early-stage and low-risk breast cancer, an MRI-linac based treatment might enable a radiosurgical, non-invasive alternative for current standard breast conserving therapy. AIM: To investigate whether single dose accelerated partial breast (APBI) to the intact tumor in both the prone and supine radiotherapy positions on the MRI-linac is dosimetrically feasible with respect to predefined coverage and organs at risk (OAR) constraints. MATERIAL & METHODS: For 20 patients with cTis or low-risk cT1N0M0 non-lobular breast carcinoma, previously treated with single dose preoperative APBI in the supine (n = 10) or prone (n = 10) position, additional intensity modulated radiotherapy plans with 7 coplanar beams in the presence of a 1.5T magnetic field were generated. A 20 Gy and 15 Gy dose was prescribed to the gross tumor and clinical target volume, respectively. The percentage of plans achieving predefined organ at risk (OAR) constraints, currently used in clinical practice, was assessed. Dosimetry differences between the prone versus supine approach and the MRI-linac versus clinically delivered plans were evaluated. RESULTS: All MRI-linac plans met the coverage and predefined OAR constraints. The prone approach appeared to be more favorable with respect to the chest wall, and ipsilateral lung dose compared to the supine position. No dosimetric differences were observed for the ipsilateral breast. No treatment position was clearly more beneficial for the skin or heart, since dosimetry varied among parameters. Overall, the MRI-linac and clinical plans were comparable, with minor absolute dosimetric differences. CONCLUSION: MRI-linac based single dose APBI to the intact tumor is a promising and a dosimetrically feasible strategy in patients with low-risk breast cancer. Preliminary OAR dosimetry favored the prone radiotherapy position.
引用
- Charaghvandi KR, Van't Westeinde T, Yoo S, et al. Single dose partial breast irradiation using an MRI linear accelerator in the supine and prone treatment position. Clin Transl Radiat Oncol. 2018. PMID: 30406210. doi:10.1016/j.ctro.2018.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。